A Challenging Clinical Scenario of ANCA-Associated Vasculitis Featuring Rapidly Progressive Crescentic Glomerulonephritis, Neutropenic Colitis, and Pancytopenia

Introduction: With a peak incidence between 65 and 75 years, though it can occur at any age, ANCA-associated vasculitis (AAV) exhibits a slight male predominance. AAV shows geographical and race/ethnic differences in prevalence and encompasses various clinicopathologic phenotypes, including granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), eosinophilic GPA (EGPA), and renal-limited necrotizing and crescentic glomerulonephritis (NCGN). It primarily affects small vessels (arteries, arterioles, venules, and veins) in any organ. The activity in the bone marrow is typically diagnosed through a biopsy with the presence of granulomas, accompanied by serum antibodies and systemic symptoms. Case Description: We present a 58-year-old with ANCA GPA vasculitis diagnosed 3 years ago. Initial symptoms included episcleritis, blurred vision, rhinitis, sinusitis, headaches, and migraines. Treatment included methotrexate, prednisone, and folic acid. In late August 2023, polyarthralgia, polyarthritis, and macroscopic hematuria emerged. Creatinine rose to 6.0, urea to 250, with neutropenic colitis due to Clostridium difficile. Suspected acute kidney injury or vasculitis activity required renal replacement therapy. A bone marrow biopsy showed no vasculitis response. Tests for ANA, SSA/Ro, HIV, HCV, HBV were negative. Kidney biopsy revealed small vessel pauciimmune vasculitis. Improvement followed rituximab induction. Glomerular filtration rate is 30 ml/min, and the patient is hemodialysis free Discussion: This case underscores the significance of performing biopsies to diagnose AAV in patients with systemic activity. Even though the patient's bone marrow biopsy showed no evidence of granulomas and they were exposed to methotrexate despite prophylactic treatment, it is possible that systemic vasculitis activity affected the bone marrow, which went undiagnosed in the sample obtained. These cases emphasize the need for a comprehensive clinical evaluation and interdisciplinary management.

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2024-10-01
DOI
https://doi.org/10.1681/asn.20248bxvg11s
Primary Topic
Vasculitis and related conditions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Challenging Clinical Scenario of ANCA-Associated Vasculitis Featuring Rapidly Progressive Crescentic Glomerulonephritis, Neutropenic Colitis, and Pancytopenia

F Arevalo, Zito Viegas da Cruz, Vicente Martı́nez, Sergio González et al.
Journal of the American Society of Nephrology
Vasculitis and related conditions
article

A Challenging Clinical Scenario of ANCA-Associated Vasculitis Featuring Rapidly Progressive Crescentic Glomerulonephritis, Neutropenic Colitis, and Pancytopenia

F Arevalo, Zito Viegas da Cruz, Vicente Martı́nez, Sergio González, Jorge Carlos Collazo Meléndez, Erick Ivan Marrero Santiago, Valeria Mora, Cristian Xavier Rivera - Benitez, David Pagan Maldonado, Andres Aranda, Licet Gonzalez Fabian, David Antonio Maldonado-Ruiz, Juan A. Morciego, Javier A. Morciego, Faviola Marie Negrón
article en

Abstract

Introduction: With a peak incidence between 65 and 75 years, though it can occur at any age, ANCA-associated vasculitis (AAV) exhibits a slight male predominance. AAV shows geographical and race/ethnic differences in prevalence and encompasses various clinicopathologic phenotypes, including granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), eosinophilic GPA (EGPA), and renal-limited necrotizing and crescentic glomerulonephritis (NCGN). It primarily affects small vessels (arteries, arterioles, venules, and veins) in any organ. The activity in the bone marrow is typically diagnosed through a biopsy with the presence of granulomas, accompanied by serum antibodies and systemic symptoms. Case Description: We present a 58-year-old with ANCA GPA vasculitis diagnosed 3 years ago. Initial symptoms included episcleritis, blurred vision, rhinitis, sinusitis, headaches, and migraines. Treatment included methotrexate, prednisone, and folic acid. In late August 2023, polyarthralgia, polyarthritis, and macroscopic hematuria emerged. Creatinine rose to 6.0, urea to 250, with neutropenic colitis due to Clostridium difficile. Suspected acute kidney injury or vasculitis activity required renal replacement therapy. A bone marrow biopsy showed no vasculitis response. Tests for ANA, SSA/Ro, HIV, HCV, HBV were negative. Kidney biopsy revealed small vessel pauciimmune vasculitis. Improvement followed rituximab induction. Glomerular filtration rate is 30 ml/min, and the patient is hemodialysis free Discussion: This case underscores the significance of performing biopsies to diagnose AAV in patients with systemic activity. Even though the patient's bone marrow biopsy showed no evidence of granulomas and they were exposed to methotrexate despite prophylactic treatment, it is possible that systemic vasculitis activity affected the bone marrow, which went undiagnosed in the sample obtained. These cases emphasize the need for a comprehensive clinical evaluation and interdisciplinary management.

Journal of the American Society of NephrologyVol. 35(10S)
Universidad Autónoma de Guadalajara (MX)
Good health and well-being
Openalex Percentile: Top 65%
Vasculitis and related conditions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.